Cargando…

Risk knowledge of people with relapsing-remitting multiple sclerosis – Results of an international survey

BACKGROUND: Adequate disease and treatment-related risk knowledge of people with Multiple Sclerosis (pwMS) is a prerequisite for informed choices in medical encounters. Previous work showed that MS risk knowledge is low among pwMS and role preferences are different in Italy and Germany. OBJECTIVE: W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giordano, Andrea, Liethmann, Katrin, Köpke, Sascha, Poettgen, Jana, Rahn, Anne Christin, Drulovic, Jelena, Beckmann, Yesim, Sastre-Garriga, Jaume, Galea, Ian, Heerings, Marco, Jongen, Peter Joseph, Vettorazzi, Eik, Solari, Alessandra, Heesen, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264873/ https://www.ncbi.nlm.nih.gov/pubmed/30496233 http://dx.doi.org/10.1371/journal.pone.0208004

Ejemplares similares

Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial
por: Rahn, Anne Christin, et al.
Publicado: (2015)

Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0) - Development of an Outcome Instrument for Educational Interventions
por: Heesen, C., et al.
Publicado: (2015)

Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis—a randomized controlled trial
por: Baquet, Lisa, et al.
Publicado: (2018)

Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol
por: Lehnert, Thomas, et al.
Publicado: (2022)

Role Preferences of People with Multiple Sclerosis: Image-Revised, Computerized Self-Administered Version of the Control Preference Scale
por: Solari, Alessandra, et al.
Publicado: (2013)

Evaluation of an interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2): study protocol for a process evaluation accompanying a randomised controlled trial
por: Wenzel, Lisa, et al.
Publicado: (2021)

Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS—understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial
por: Schiffmann, Insa, et al.
Publicado: (2020)

EAN Guideline on Palliative Care of People with Severe, Progressive Multiple Sclerosis
por: Solari, Alessandra, et al.
Publicado: (2020)

Reasons for delayed admission after stroke: results of a qualitative and quantitative survey
por: Alegiani, Anna Christina, et al.
Publicado: (2019)

An interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2) - development, feasibility, and pilot testing of a complex intervention
por: Wenzel, Lisa, et al.
Publicado: (2022)

Magnetic Resonance Imaging in Multiple Sclerosis – Patients' Experiences, Information Interests and Responses to an Education Programme
por: Brand, Judith, et al.
Publicado: (2014)

The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis
por: Derfuss, T, et al.
Publicado: (2020)

Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial
por: Rahn, Anne Christin, et al.
Publicado: (2021)

Correction to: Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial
por: Rahn, Anne Christin, et al.
Publicado: (2021)

Training doctors briefly and in situ to involve their patients in making medical decisions—Preliminary testing of a newly developed module
por: Kasper, Jürgen, et al.
Publicado: (2017)

Quality of Stroke Patient Information Applied in Randomized Controlled Trials—Literature Review
por: Alegiani, Anna C., et al.
Publicado: (2020)

Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study
por: Jongen, Peter Joseph, et al.
Publicado: (2014)

Adherence to behavioural interventions in multiple sclerosis: Follow-up meeting report (AD@MS-2)
por: Heesen, Christoph, et al.
Publicado: (2015)

An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol
por: Jongen, Peter Joseph, et al.
Publicado: (2016)

The MS@Work study: a 3-year prospective observational study on factors involved with work participation in patients with relapsing-remitting Multiple Sclerosis
por: van der Hiele, Karin, et al.
Publicado: (2015)

Revista de Neurología cumple medio siglo
por: Sastre-Garriga, Jaume
Publicado: (2023)

Applying the theory of planned behaviour to multiple sclerosis patients’ decisions on disease modifying therapy – questionnaire concept and validation
por: Kasper, Jürgen, et al.
Publicado: (2012)

Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later
por: Jongen, Peter Joseph, et al.
Publicado: (2016)

Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2021)

Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A single-centre randomized controlled trial
por: Jongen, Peter Joseph, et al.
Publicado: (2019)

Prognostic factors for long-term outcomes in relapsing–remitting multiple sclerosis
por: Traboulsee, Anthony L, et al.
Publicado: (2016)

Impact of a multimedia website with patient experiences of multiple sclerosis (PExMS) on immunotherapy decision-making: study protocol for a pilot randomised controlled trial in a mixed-methods design
por: Barabasch, Anna, et al.
Publicado: (2021)

A new graphical format to communicate treatment effects to patients—A web‐based randomized controlled trial
por: Kasper, Jürgen, et al.
Publicado: (2016)

‘That would have been the perfect thing after diagnosis’: development of a digital lifestyle management application in multiple sclerosis
por: Krause, Nicole, et al.
Publicado: (2022)

Cerebellar Information Processing in Relapsing-Remitting Multiple Sclerosis (RRMS)
por: Lesage, E., et al.
Publicado: (2010)

Cognitive functioning as a predictor of employment status in relapsing-remitting multiple sclerosis: a 2-year longitudinal study
por: van Gorp, Dennis A.M., et al.
Publicado: (2019)

Lipid Mediator Profiles Predict Response to Therapy with an Oral Frankincense Extract in Relapsing-Remitting Multiple Sclerosis
por: Stürner, Klarissa Hanja, et al.
Publicado: (2020)

Comprehension of confidence intervals - development and piloting of patient information materials for people with multiple sclerosis: qualitative study and pilot randomised controlled trial
por: Rahn, Anne C., et al.
Publicado: (2016)

Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability
por: Has Silemek, Arzu Ceylan, et al.
Publicado: (2020)

VALIDATION OF THE BRIEF INTERNATIONAL COGNITIVE ASSESSMENT FOR MULTIPLE SCLEROSIS (BICAMS) IN A LARGE COHORT OF RELAPSING-REMITTING MS PATIENTS
por: Drulović, Jelena, et al.
Publicado: (2022)

Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing–remitting MS
por: Stellmann, Jan‐Patrick, et al.
Publicado: (2016)

Role of IL-16 in CD4(+) T cell-mediated regulation of relapsing multiple sclerosis
por: Skundric, Dusanka S, et al.
Publicado: (2015)

Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial
por: Bellmann-Strobl, Judith, et al.
Publicado: (2021)

Editorial: Shared decision-making in neurology
por: Heesen, Christoph, et al.
Publicado: (2023)

Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?
por: Jongen, Peter Joseph, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_661pehdudvgh971d3bepfcmto6